As a national medicine shortage worsens, Lipitor (atorvastatin) — a statin medication used to prevent cardiovascular disease in high-risk cases, as well as abnormal lipid levels — has been among hardest to source. Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) has said that the shortage would not put citizens’ health in jeopardy, as there are other generic drugs that offer the same effect.
The National Health Insurance Administration has been promoting the “same ingredients, same dosage form, same component” policy for years. The problem is that people still fall victim to media hype whenever there are reports of a shortage of a single brand of drug, forcing the government to repeatedly clarify the issue. If people can learn to regard generic drugs as an alternative to brand-name medicines, there would be a lot less confusion and commotion.
The Federation of Taiwan Pharmacists’ Associations once conducted an online poll, with only half of the participants saying they supported the administration’s policy.
Asked if the statement “I would not go the community pharmacy for drugs over concerns that the prescription drug on offer is not a brand-name drug” applied to them, only 40 percent of participants said that they had never had this concern.
Despite pharmacists’ efforts to convince customers that generic drugs are not counterfeit and are alternative medications developed by other companies that offer the same effect as brand-name drugs, people are still unable to shake off their bias and fixed perceptions. This herd mentality not only causes meaningless panic, but hinders Taiwan’s development of generic drugs.
While generic drugs account for the majority of Taiwan’s pharmaceutical manufacturing industry, generics overall account for nearly 70 percent of the quantity, but less than 30 percent of the cost of items covered by the National Health Insurance.
It goes without saying that without demand, local drug companies would not pour more resources into research and development, leaving the generic drug industry to stagnate.
Taiwan became a member of the Pharmaceutical Inspection Convention and Co-operation Scheme in 2015, indicating that Taiwan’s manufactured drugs meet the global standard.
Under the promotion of the Federation of Taiwan Pharmacists’ Associations and the collaboration of hospitals and institutions, most of the refillable prescriptions for patients with chronic illnesses are no longer labeled as “noninterchangeable.”
However, there are still cases in which hospitals have told patients that they have prescribed them “brand-name drugs,” giving people the false impression that they were given medication of superior quality.
Hsueh hit the nail on the head when he said that it is not true when people claim they are not used to generic drugs. Nonetheless, other than relying on pharmacists to teach the public about efficacy of generic medication, the government should create resources and systematically teach the public about generic drugs.
The government should step up its supervision of hospitals. In countries such as Canada, the UK and the US, pharmacists have to list the ingredients of the drug on prescriptions to avoid patients misunderstanding them.
Even though it is a Herculean task to educate the public, peoples’ misconceptions about generic drugs have influenced the drug manufacturing industry and the National Health Insurance system. Only by implementing reforms can the government clear the stigma of generic drugs, enhance the development of the industry and improve citizens’ medication welfare.
Huang Jin-shun is president of the Federation of Taiwan Pharmacists’ Associations.
Translated by Rita Wang
Apart from the first arms sales approval for Taiwan since US President Donald Trump took office, last month also witnessed another milestone for Taiwan-US relations. Trump signed the Taiwan Assurance Implementation Act into law on Tuesday. Its passing without objection in the US Senate underscores how bipartisan US support for Taiwan has evolved. The new law would further help normalize exchanges between Taiwanese and US government officials. We have already seen a flurry of visits to Washington earlier this summer, not only with Minister of Foreign Affairs Lin Chia-lung (林佳龍), but also delegations led by National Security Council Secretary-General Joseph Wu
In A phone call between US President Donald Trump and Chinese President Xi Jinping (習近平), Xi is reported to have stated that in his view, “Taiwan’s return to China” is to be considered an integral part of the post-World War II international order. Never mind that China under Xi has been trying to undermine the liberal post-war international order by setting up alternative organizations and schemes that are detrimental to freedom and democracy around the world. Its own repression of Tibet, Xinjiang and Hong Kong are vivid examples. The “return to China” is the biggest misnomer: Taiwan has never ever been part
When the towers of Wang Fuk Court turned into a seven-building inferno on Wednesday last week, killing 128 people, including a firefighter, Hong Kong officials promised investigations, pledged to review regulations and within hours issued a plan to replace bamboo scaffolding with steel. It sounded decisive. It was not. The gestures are about political optics, not accountability. The tragedy was not caused by bamboo or by outdated laws. Flame-retardant netting is already required. Under Hong Kong’s Mandatory Building Inspection Scheme — which requires buildings more than 30 years old to undergo inspection every decade and compulsory repairs — the framework for
President William Lai (賴清德) on Wednesday last week announced a plan to invest an additional NT$1.25 trillion (US$39.8 billion) in military spending to procure advanced defense systems over the next eight years, and outlined two major plans and concrete steps to defend democratic Taiwan in the face of China’s intensifying threat. While Lai’s plans for boosting the country’s national security have been praised by many US lawmakers, former defense officials, academics and the American Institute in Taiwan, the US’ de facto embassy in Taiwan, they were not equally welcomed by all Taiwanese, particularly among the opposition parties. Chinese Nationalist Party (KMT) Chairwoman